Alphyn Biologics, Inc., a clinical-stage dermatology company developing first-in-class Multi-Target Therapeutics®, today announced the close of its $25 million, twice-oversubscribed Series B financing ...
Copyright © 2025 Insider Inc and finanzen.net GmbH (Imprint). All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Service ...
Copyright © 2025 Insider Inc and finanzen.net GmbH (Imprint). All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Service ...
A surprise investor has quietly taken Byju Raveendran’s place in Aakash’s ₹250 crore rights issue, triggering fresh doubts ...
The Delaware Court had earlier ordered Raveendran to pay more than $1 billion, saying the former corporate star refused to ...
Facebook on MSN
Get the best brakes for the Toyotas!
An overview of the most reliable brake options for Toyota vehicles, comparing performance and durability to help drivers ...
The US bankruptcy court has set aside the monetary portion of its November 20 default judgment, saying damages were never ...
One of the most significant changes is the adoption of a dual-session board exam format. Starting in 2026, the board will now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback